Xiaoli Meng

2.8k total citations
108 papers, 2.1k citations indexed

About

Xiaoli Meng is a scholar working on Pharmacology, Pharmacology and Immunology. According to data from OpenAlex, Xiaoli Meng has authored 108 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pharmacology, 24 papers in Pharmacology and 23 papers in Immunology. Recurrent topics in Xiaoli Meng's work include Drug-Induced Adverse Reactions (38 papers), Drug-Induced Hepatotoxicity and Protection (16 papers) and Pharmacogenetics and Drug Metabolism (15 papers). Xiaoli Meng is often cited by papers focused on Drug-Induced Adverse Reactions (38 papers), Drug-Induced Hepatotoxicity and Protection (16 papers) and Pharmacogenetics and Drug Metabolism (15 papers). Xiaoli Meng collaborates with scholars based in United Kingdom, United States and China. Xiaoli Meng's co-authors include Dean J. Naisbitt, Andrew V. Stachulski, Rosalind E. Jenkins, Munir Pirmohamed, James L. Maggs, J. Waddington, Paul Whitaker, Arun Tailor, B. Kevin Park and Neil French and has published in prestigious journals such as The Lancet, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Xiaoli Meng

95 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoli Meng United Kingdom 26 812 444 440 306 239 108 2.1k
B. Kevin Park United Kingdom 25 704 0.9× 786 1.8× 566 1.3× 402 1.3× 166 0.7× 36 2.5k
Gary Gordon United States 35 623 0.8× 1.4k 3.2× 294 0.7× 239 0.8× 266 1.1× 105 4.4k
Heng Luo China 27 366 0.5× 1.1k 2.5× 254 0.6× 168 0.5× 231 1.0× 90 2.3k
Yaning Wang United States 29 380 0.5× 769 1.7× 547 1.2× 373 1.2× 36 0.2× 117 3.4k
Pei Hu China 26 271 0.3× 778 1.8× 392 0.9× 158 0.5× 118 0.5× 222 2.6k
Yan Cao China 34 250 0.3× 2.1k 4.6× 360 0.8× 370 1.2× 122 0.5× 172 3.5k
Elaine Lai‐Han Leung Macao 40 420 0.5× 2.6k 5.8× 427 1.0× 531 1.7× 264 1.1× 143 4.7k
Brian Booth United States 30 337 0.4× 1.6k 3.6× 265 0.6× 815 2.7× 193 0.8× 77 4.6k
Qibiao Wu Macao 30 237 0.3× 1.2k 2.8× 214 0.5× 301 1.0× 117 0.5× 147 2.6k
Ying Zhou China 30 156 0.2× 2.0k 4.5× 232 0.5× 250 0.8× 196 0.8× 128 3.8k

Countries citing papers authored by Xiaoli Meng

Since Specialization
Citations

This map shows the geographic impact of Xiaoli Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Meng more than expected).

Fields of papers citing papers by Xiaoli Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoli Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Meng. The network helps show where Xiaoli Meng may publish in the future.

Co-authorship network of co-authors of Xiaoli Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoli Meng. A scholar is included among the top collaborators of Xiaoli Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoli Meng. Xiaoli Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Lele, Pengcheng Huai, Zhenzhen Wang, et al.. (2025). TSC22 domain family member 3 links natural killer cells to CD8+ T cell-mediated drug hypersensitivity. Signal Transduction and Targeted Therapy. 10(1). 196–196.
2.
Meng, Xiaoli. (2025). Data Science and AI:  Everything Everywhere All at Once. Harvard Data Science Review. 7(1).
3.
4.
Meng, Xiaoli. (2024). AI Has Won Nobel Prizes in Hard Science: Can Humans Be Smarter—and Softer on Each Other?. SHILAP Revista de lepidopterología. 6(4). 1 indexed citations
5.
Meng, Xiaoli, et al.. (2024). A Conversation With Tim Ritchie, President of the Museum of Science, Boston. SHILAP Revista de lepidopterología. 6(2).
6.
7.
Lo, Andrew W., Xiaoli Meng, & Liberty Vittert. (2023). From Financial Markets to ChatGPT: A Conversation With Andrew Lo. SHILAP Revista de lepidopterología. 5(4).
8.
Almutairi, Mubarak, Adam Lister, Qing Zhao, et al.. (2023). Activation of Human CD8+ T Cells with Nitroso Dapsone–Modified HLA-B*13:01–Binding Peptides. The Journal of Immunology. 210(8). 1031–1042. 3 indexed citations
9.
Iyer, Seema, Xiaoli Meng, & Liberty Vittert. (2023). Close to Refuge: Integrating AI and Human Insights for Intervention and Prevention: A Conversation With Seema Iyer. SHILAP Revista de lepidopterología. 5(4).
10.
Meng, Xiaoli, et al.. (2023). Why drug exposure is frequently associated with T-cell mediated cutaneous hypersensitivity reactions. SHILAP Revista de lepidopterología. 5. 1268107–1268107. 3 indexed citations
11.
Olsson‐Brown, Anna, Andrew Gibson, Joshua Gardner, et al.. (2021). Checkpoint Inhibition Reduces the Threshold for Drug-Specific T-Cell Priming and Increases the Incidence of Sulfasalazine Hypersensitivity. Toxicological Sciences. 186(1). 58–69. 27 indexed citations
12.
Zhao, Qing, Mubarak Almutairi, Arun Tailor, et al.. (2021). HLA Class-II‒Restricted CD8+ T Cells Contribute to the Promiscuous Immune Response in Dapsone-Hypersensitive Patients. Journal of Investigative Dermatology. 141(10). 2412–2425.e2. 16 indexed citations
13.
Amporndanai, Kangsa, Xiaoli Meng, Weijuan Shang, et al.. (2021). Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives. Nature Communications. 12(1). 3061–3061. 178 indexed citations
14.
Ogese, Monday O., Adam Lister, Rosalind E. Jenkins, et al.. (2020). Characterization of Clozapine-Responsive Human T Cells. The Journal of Immunology. 205(9). 2375–2390. 13 indexed citations
15.
Fineberg, Harvey V., Victoria Stodden, & Xiaoli Meng. (2020). Highlights of the US National Academies Report on “Reproducibility and Replicability in Science”. SHILAP Revista de lepidopterología. 2(4). 7 indexed citations
16.
Ariza, Adriana, Rubén Fernández‐Santamaría, Xiaoli Meng, et al.. (2020). Characterization of amoxicillin and clavulanic acid specific T‐cell clones from patients with immediate drug hypersensitivity. Allergy. 75(10). 2562–2573. 11 indexed citations
17.
Meng, Xiaoli. (2020). What Is Your List of 10 Challenges in Data Science?. SHILAP Revista de lepidopterología. 4 indexed citations
18.
Hammond, Thomas, Xiaoli Meng, Rosalind E. Jenkins, et al.. (2014). Mass Spectrometric Characterization of Circulating Covalent Protein Adducts Derived from a Drug Acyl Glucuronide Metabolite: Multiple Albumin Adductions in Diclofenac Patients. Journal of Pharmacology and Experimental Therapeutics. 350(2). 387–402. 50 indexed citations
19.
Dong, Jiamei, Wei Du, Yuan Li, et al.. (2012). A new novel mutation in FBN1 causes autosomal dominant Marfan syndrome in a Chinese family.. PubMed. 18. 81–6. 21 indexed citations
20.
Meng, Xiaoli, Husheng Li, K WANG, et al.. (2007). Fidelity genotyping of point mutation by enhanced melting point difference using DNA ligase. Talanta. 73(1). 23–29. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. Kevin Park Breakdown of academic impact, for papers by Gary Gordon Breakdown of academic impact, for papers by Heng Luo Breakdown of academic impact, for papers by Yaning Wang Breakdown of academic impact, for papers by Pei Hu Breakdown of academic impact, for papers by Yan Cao Breakdown of academic impact, for papers by Elaine Lai‐Han Leung Breakdown of academic impact, for papers by Brian Booth Breakdown of academic impact, for papers by Qibiao Wu Breakdown of academic impact, for papers by Ying Zhou
Rankless by CCL
2026